Caricamento...

Efficacy and Safety of Nebulized Glycopyrrolate/eFlow® Closed System in Patients with Moderate-to-Very-Severe Chronic Obstructive Pulmonary Disease with Pre-Existing Cardiovascular Risk Factors

Purpose: The purpose of this study was to assess the effect of pre-existing cardiovascular (CV) risk factors on the efficacy and safety of nebulized glycopyrrolate (GLY) in patients with chronic obstructive pulmonary disease (COPD). Methods: A total of 2379 patients from 3 phase III studies (12-week...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Chronic Obstr Pulm Dis
Autori principali: Ferguson, Gary T., Tosiello, Robert, Sanjar, Shahin, Goodin, Thomas
Natura: Artigo
Lingua:Inglês
Pubblicazione: COPD Foundation Inc 2018
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6373592/
https://ncbi.nlm.nih.gov/pubmed/30775427
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15326/jcopdf.6.1.2018.0146
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !